MedPath

Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola

Not Applicable
Completed
Conditions
Papillary Thyroid Carcinoma
Registration Number
NCT05760690
Lead Sponsor
Sun Yat-sen University
Brief Summary

The goal of this retrospective study is to compare the safety and efficiacy of endoscopic thyroidectomy via retro-auricular single-site approach, transoral endoscopic thyroidectomy vestibular approach and transareola approach.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  1. Age 18-70 years old, no gender restrictions.
  2. Fine-needle aspiration cytology(FNA) confirmed papillary thyroid carcinoma(PTC).
  3. Early stage PTC (stage T1N0M0).
  4. Preoperative ultrasonography showed unilateral glandular lobe malignant tumor and the largest diameter was not more than 2cm, without cervical lymph node metastasis and extensive metastasis.
  5. Patients undergoing thyroid lobectomy and central lymph node dissection.
  6. Patients who have signed an approved Informed Consent.
Exclusion Criteria
  1. Patients who do not accept case data collection for various reasons.
  2. The clinical data unfit this study (at the discretion of the investigator).
  3. Patients who have undergone neck surgery or radiotherapy before this trail.
  4. Patients who have uncontrolled hyperthyroidism.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
C-reactive protein,CRP1 week

the level of CRP before and after operation

Secondary Outcome Measures
NameTimeMethod
blood loss1 week

The volume of blood loss during operation

number of lymph nodes1 week after operation

Postoperative specimen Postoperative specimen Postoperative specimen Postoperative specimen the number of lymph nodes in postoperative specimens

VAS pain score2 days after operation

Postoperative VAS score was recorded

Serum Amyloid A,SAA1 week

the level of CRP before and after operation

Trial Locations

Locations (1)

Sun Yat-Sen University Cancer Center

🇨🇳

Guangzhou, Guangdong, China

Sun Yat-Sen University Cancer Center
🇨🇳Guangzhou, Guangdong, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.